TY  - JOUR 
AU  - Borrás Pérez, Victoria
AU  - López-Siguero, Juan Pedro
AU  - Martínez, Gabriela
AU  - Corripio, Raquel
AU  - Fernández, Juan Manuel
AU  - Labarta, Jose Ignacio
AU  - Ferrer, Marta
AU  - Cabrinety, Nuria
AU  - Ramón-Krauel, Marta
AU  - Bosch, Jordi
AU  - Espino, Rafael
AU  - Palla Garcia, Margarida
AU  - Rebollo, Francisco Jose
AU  - Prieto Matos, Pablo
PY  - 2015
SN  - 0741-238X
UR  - http://hdl.handle.net/10366/155658
AB  - An initial Phase III clinical trial has evaluated the efficacy and safety of biosimilar recombinant human growth hormone (rhGH; Omnitrope(®), Sandoz) in Spanish children with growth hormone deficiency (GHD). At the end of the study, those patients...
LA  - eng
KW  - Growth Disorders
KW  - Human Growth Hormone
KW  - Biosimilar Pharmaceuticals
KW  - Follow-Up Studies
KW  - Humans
KW  - Body Height
KW  - Adolescent
KW  - Retrospective Studies
TI  - A follow-up study to monitor adult height among Spanish children with growth hormone deficiency who received biosimilar human recombinant growth hormone (Omnitrope®) during a phase III clinical trial
DO  - 10.1007/s12325-015-0181-9
T2  - Advances in Therapy
VL  - 32
M2  - 148
ER  -